Select Medical Holdings Co. (NYSE:SEM) Shares Bought by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL boosted its position in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 291.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 496,724 shares of the health services provider's stock after acquiring an additional 369,760 shares during the period. Tudor Investment Corp ET AL owned 0.38% of Select Medical worth $9,363,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Quarry LP lifted its stake in shares of Select Medical by 963.0% during the 4th quarter. Quarry LP now owns 9,078 shares of the health services provider's stock valued at $171,000 after buying an additional 8,224 shares in the last quarter. Boothbay Fund Management LLC purchased a new position in shares of Select Medical in the fourth quarter valued at about $228,000. Susquehanna Fundamental Investments LLC bought a new position in shares of Select Medical in the fourth quarter worth about $988,000. HBK Investments L P purchased a new stake in shares of Select Medical during the fourth quarter worth about $188,000. Finally, Voya Investment Management LLC raised its stake in Select Medical by 20.9% during the 4th quarter. Voya Investment Management LLC now owns 1,013,366 shares of the health services provider's stock valued at $19,102,000 after purchasing an additional 174,911 shares during the period. Hedge funds and other institutional investors own 89.48% of the company's stock.

Select Medical Stock Up 4.6 %

Select Medical stock traded up $0.66 during trading hours on Monday, reaching $14.92. The stock had a trading volume of 1,628,676 shares, compared to its average volume of 1,015,723. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The company has a market cap of $1.92 billion, a price-to-earnings ratio of 9.07, a PEG ratio of 0.64 and a beta of 1.38. The business's 50 day moving average price is $16.91 and its 200-day moving average price is $21.65. Select Medical Holdings Co. has a 52 week low of $14.03 and a 52 week high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing analysts' consensus estimates of $0.45 by ($0.01). The business had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.40 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company's quarterly revenue was down 24.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.75 earnings per share. Sell-side analysts anticipate that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th will be issued a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.68%. The ex-dividend date is Thursday, May 15th. Select Medical's payout ratio is 15.15%.

Select Medical announced that its board has approved a share buyback plan on Thursday, May 1st that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the health services provider to buy up to 42.6% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's management believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. StockNews.com upgraded Select Medical from a "hold" rating to a "buy" rating in a research report on Friday, February 21st. Royal Bank of Canada decreased their price objective on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a research note on Monday, February 24th. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price for the company in a research note on Monday, February 24th. Finally, Mizuho began coverage on Select Medical in a report on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price objective on the stock. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $26.80.

Insider Buying and Selling at Select Medical

In other Select Medical news, CEO David S. Chernow sold 225,000 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the sale, the chief executive officer now directly owns 714,516 shares of the company's stock, valued at approximately $12,861,288. This trade represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 11.60% of the company's stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.